PD Dr. Andreas Kremer

Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology Professur für Biochemie und Molekulare Pathobiologie

Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinoma (2023) Scheiner B, Roessler D, Phen S, Lim M, Pomej K, Pressiani T, Cammarota A, et al. Journal article Influence of the autotaxin-lysophosphatidic acid axis on cellular function and cytokine expression in different breast cancer cell lines (2022) Hauck T, Kadam S, Heinz K, Garcia Peraza M, Schmid R, Kremer A, Wolf K, et al. Journal article Generalized resistance to pruritogen-induced scratching in the C3H/HeJ strain (2022) Zhang Y, Richter N, König C, Kremer A, Zimmermann K Journal article S2k Leitlinie: Diagnostik und Therapie des chronischen Pruritus (2022) Ständer S, Zeidler C, Augustin M, Darsow U, Kremer A, Legat FJ, Koschmieder S, et al. Journal article S2k guideline: Diagnosis and treatment of chronic pruritus (2022) Ständer S, Zeidler C, Augustin M, Darsow U, Kremer A, Legat FJ, Koschmieder S, et al. Journal article HLA-DO: a possible switch between GvHD and GvL effect (2022) Zeun J, Neubeck S, Lang V, Flamann C, Nagel L, Kunert T, Vogler T, et al. Conference contribution Increased CD47 expression inhibits phagocytosis of alloreactive donor T cells after allo-HSCT (2022) Flamann C, Matos C, Kreutz M, Shaikh H, Beilhack A, Büttner-Herold M, Lischer C, et al. Conference contribution Chronic pruritus represents a major burden in non-cholestatic hepatobiliary disorders (2022) Düll M, Karlen V, Vetter M, Dietrich P, Kupfer J, Neurath M, Kremer A Conference contribution Impact on follow-up strategies in patients with primary sclerosing cholangitis (2022) Bergquist A, Weismueller TJ, Levy C, Rupp C, Joshi D, Nayagam JS, Montano-Loza AJ, et al. Journal article Lysophosphatidic acid activates nociceptors and causes pain or itch depending on the application mode in human skin (2022) Düll M, Stengel M, Ries V, Strupf M, Reeh P, Kremer A, Namer B Journal article